apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer (2022) Christensen E, Wyatt AW, Galsky MD, Grivas P, Seiler R, Nawroth R, Goebell P, et al. Journal article, Review article Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer -data from the non-interventional LEAN study (2022) Schmitz-Dräger BJ, Bismarck E, Grammenos D, Ebert T, Starlinger R, Ottillinger B, Goebell P, et al. Journal article Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III (2022) Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TC, Strandgaard T, Kamat AM, Williams SB, et al. Journal article, Review article Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria (2022) Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, et al. Journal article Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? Comment (2022) Roghmann F, Goebell P, Dyrskjot L, van Rhijn BWG, Kaefferlein HU, Hakenberg O, Stenzl A, et al. Journal article, Editorial Cell-free dna variant sequencing using plasma and ar-v7 testing of circulating tumor cells in prostate cancer patients (2021) Lieb V, Bellut L, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, et al. Journal article Geriatric Assessments Can Predict Functional Outcome and Mortality after Urological Tumor Surgery (2021) Kahlmeyer A, Fiebig C, Müller M, Kraulich M, Brendel-Suchanek J, Kunath F, Wach S, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article Thrombospondin‐2 and ldh are putative predictive biomarkers for treatment with everolimus in second‐line metastatic clear cell renal cell carcinoma (Marc‐2 study) (2021) Zeuschner P, Hölters S, Stöckle M, Seliger B, Mueller A, Bachmann HS, Grünwald V, et al. Journal article TROPiCS-04: Study of sacituzumab govitecan in metastatic or locally advanced unresectable urothelial cancer that has progressed after platinum and checkpoint inhibitor therapy. (2021) Grivas P, Tagawa ST, Bellmunt J, De Santis M, Duran I, Goebell P, Necchi A, et al. Conference contribution